ArticlePharmaceutical research2026

PK-PD Modeling Suggests Tumor Heterogeneity Limits Preclinical to Clinical Translation of Enzalutamide in Prostate Cancer.

Se Jin Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.